News

New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...
A major international study presented at the 62nd ERA Congress reveals that the long-accepted survival advantage of ...
A major international study, being presented today at the 62nd ERA Congress, reveals that the long-accepted survival ...
Fresenius Medical Care (FME) has commenced the US commercialisation of its high-volume haemodiafiltration (HVHDF) kidney ...